mhurhangee/patent-ind-claim-en huggingface dataset:
An acetal-containing, UV-absorbing compound of any one of formula (I), (II), (IV) or (V) in which: R a is CH 3 or C 2 H 5 ; R o is H or CH 3 ; R 1 ; R 2 and R 2 ' independent of one other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R" in which R' and R" independent of each other are H or C 1 -C 4 alkyl, OH, or OCH 3 ; R 1 ' independent of each other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R" in which R' and R" independent of each other are H or C 1 -C 4 alkyl, OH, OCH 3 , SO 3 H, or SO 3 - Na + ; R 3 and R 4 independent of each other are H or a first hydrophilic group which is *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 , *-CH 2 -(OC 2 H 4 ) n1 -OH, provided that at least one of R 3 and R 4 is the first hydrophilic group; r1 is an integer of 3 to 6; n1 is an integer of 2 to 20 (preferably 3 to 15, more preferably 4 to 10); R 8 is CH 3 , C 2 H 5 , R 9 is SO 3 Na, R 9 ' is H, SO 3 Na, R 10 is methyl or ethyl; L1 is a linkage of or L2 is a linkage of *-CH 2 -* , C 2 H 4 -* , *-C 3 H 6 -* , *-C 3 H 6 -S-C 2 H 4 -* , *-C 3 H 6 -S-C 3 H 6 -* , or L3 is a linkage of *-(CH 2 ) r1 -* or and X1 is O or NR°; or an acetal compound selected from the group consisting of in which: R a is methyl or ethyl; R 1 and R 2 independent of each other are CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R" OH, or OCH 3 ; in which R' and R" independent of each other are H or C 1 -C 4 alkyl; R 8 is CH 3 , C 2 H 5 , R 10 is methyl or ethyl; and r1 is an integer of 3 to 6. R a is CH 3 or C 2 H 5 ; R o is H or CH 3 ; R 1 ; R 2 and R 2 ' independent of one other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R" in which R' and R" independent of each other are H or C 1 -C 4 alkyl, OH, or OCH 3 ; R 1 ' independent of each other are H, CH 3 , CCl 3 , CF 3 , Cl, Br, NR'R" in which R' and R" independent of each other are H or C 1 -C 4 alkyl, OH, OCH 3 , SO 3 H, or SO 3 - Na + ; R 3 and R 4 independent of each other are H or a first hydrophilic group which is *-CH 2 -(OC 2 H 4 ) n1 -OCH 3 , *-CH 2 -(OC 2 H 4 ) n1 -OH, provided that at least one of R 3 and R 4 is the first hydrophilic group; r1 is an integer of 3 to 6; n1 is an integer of 2 to 20 (preferably 3 to 15, more preferably 4 to 10); R 8 is CH 3 , C 2 H 5 , R 9 is SO 3 Na, R 9 ' is H, SO 3 Na, R 10 is methyl or ethyl; L1 is a linkage of or L2 is a linkage of *-CH 2 -* , C 2 H 4 -* , *-C 3 H 6 -* , *-C 3 H 6 -S-C 2 H 4 -* , *-C 3 H 6 -S-C 3 H 6 -* , or L3 is a linkage of *-(CH 2 ) r1 -* or and X1 is O or NR°;
Wrapping machine of the type comprising a turntable or a ring configured for wrapping a thermoweldable extendible plastic film around a palletised product comprising a wrapping head and a closing device (1; 101) with retaining means (6; 106), the wrapping head being configured for forming a band of said plastic film provided with an open end that projects above said palletised product by wrapping the plastic film around the palletised product and said retaining means (6; 106) of the closing device (1; 101) located above the top of the palletised product , said closing device (1; 101) being configured for closing said open end and comprising closing means arranged for bringing together portions of said band and said retaining means (6; 106) cooperating with said closing means and arranged above the top of the palletised product for supporting and retaining said plastic film of said open end and for folding said portions, said closing means being provided with a welding element for welding said portions of said band above said top , so as to close the opening of said open end , wherein said closing means comprises a pair of arms , supported by a framework and drivable in such a manner that at least respective ends of said arms are movable towards and away from one another, said welding element being fixed to each of said respective ends , and wherein said retaining means (6; 106) is connected to said arms in such a manner as to be driven by the motion of said arms between an extended configuration (E), in which said retaining means (6; 106) is suitable for maintaining said portions extended and a folded configuration (K), in which said retaining means is suitable for retaining said portions substantially superimposed on one another (H).
A pharmaceutical composition comprising: particulate cilostazol or a salt thereof having a 90% particle size in a cumulative particle size distribution of 5 to 75 μm; a water-soluble cellulose; a non-water-soluble cellulose; a diluent; and a lubricant, wherein the water-soluble cellulose constitutes 1% to 25% by weight, the non-water-soluble cellulose constitutes 20% to 40% by weight, and the particulate cilostazol or salt thereof constitutes 15% to 70% by weight of the pharmaceutical composition that is in solid, extended-release form and features an in vivo plasma profile for cilostazol of C 24h /C max > 0.25; and the non-water-soluble cellulose is ethylcellulose, cellulose acetate, methylcellulose, or a combination thereof. particulate cilostazol or a salt thereof having a 90% particle size in a cumulative particle size distribution of 5 to 75 μm; a water-soluble cellulose; a non-water-soluble cellulose; a diluent; and a lubricant, wherein the water-soluble cellulose constitutes 1% to 25% by weight, the non-water-soluble cellulose constitutes 20% to 40% by weight, and the particulate cilostazol or salt thereof constitutes 15% to 70% by weight of the pharmaceutical composition that is in solid, extended-release form and features an in vivo plasma profile for cilostazol of C 24h /C max > 0.25; and the non-water-soluble cellulose is ethylcellulose, cellulose acetate, methylcellulose, or a combination thereof.
A drink making device , comprising: a base configured to support a bottle arranged to contain a liquid; a hood ; a tower connecting the base and the hood ; a connector disposed in the hood and configured to receive liquid from the bottle ; a pump for drawing liquid out of the bottle ; and a dispenser for dispensing a beverage which comprises liquid from the bottle ; characterized by further comprising: a rigid tube configured to project into the bottle ; and a coupler disposed in the hood and selectively connectable to an end of the rigid tube to engage the bottle with the drink making device; wherein the drink making device is configured such that, in use, liquid may be drawn out of the bottle by the pump through the rigid tube , through the coupler and the connector , and dispensed through the dispenser .
Hybrid organic-inorganic material consisting of an organic conductor polymer matrix and transparent conducting oxide nanostructures as filler, where the conductive polymer is PEDOT:PSS and the nanostructures are dispersed in the polymer in a ratio of 0.1 - 10 % wt., characterized in that said nanostructures have tin and /or titanium oxide nanowires undoped or doped with Cr, Al, or Li with a cationic percentage range of 1 to 40% and the nanowires have sections of up to a 100 nm and lengths of up to 1000 nm.
A method for reducing the number of pathogens in a liquid, the method comprising: (a) diffusing a liquid into droplets by at least one nozzle , while subjecting the liquid to a pressure drop of eight Bars or more, wherein the pressure drop occurs between a nozzle inlet and a nozzle outlet , wherein the nozzle outlet is positioned in an inner cavity of a reactor ; and (b) after diffusing the liquid into droplets, collecting the droplets inside of a reservoir in the inner cavity of the reactor to create a volume of liquid and increasing the temperature of the volume of liquid by 10°C or more. (a) diffusing a liquid into droplets by at least one nozzle , while subjecting the liquid to a pressure drop of eight Bars or more, wherein the pressure drop occurs between a nozzle inlet and a nozzle outlet , wherein the nozzle outlet is positioned in an inner cavity of a reactor ; and (b) after diffusing the liquid into droplets, collecting the droplets inside of a reservoir in the inner cavity of the reactor to create a volume of liquid and increasing the temperature of the volume of liquid by 10°C or more.
A surgical stapler for stapling the stomach tissue of a patient, comprising: a handle ; a shaft extending from said handle; an end effector extending from said shaft, wherein said end effector comprises: a plurality of staples ; and an anvil configured to deform said staples; and a firing system configured to deploy said staples along a firing path (SP 1 , SP 2 ); characterised in that : said handle comprises a display , and the surgical stapler further comprises a vision system configured to capture a tissue image of the stomach tissue and a controller comprising an edge detection algorithm configured to determine at least a portion of the perimeter of the stomach tissue, wherein the controller is configured to generate an image representing at least a portion of the perimeter of the stomach tissue, wherein the controller is configured to display said image representing at least a portion of the edge perimeter of the stomach tissue over at least a portion of said tissue image on said display ; and wherein said controller is further configured to generate said firing path based on the determined at least a portion of the perimeter of the stomach. a handle ; a shaft extending from said handle; an end effector extending from said shaft, wherein said end effector comprises: a plurality of staples ; and an anvil configured to deform said staples; and a plurality of staples ; and an anvil configured to deform said staples; and a firing system configured to deploy said staples along a firing path (SP 1 , SP 2 ); characterised in that : said handle comprises a display , and the surgical stapler further comprises a vision system configured to capture a tissue image of the stomach tissue and a controller comprising an edge detection algorithm configured to determine at least a portion of the perimeter of the stomach tissue, wherein the controller is configured to generate an image representing at least a portion of the perimeter of the stomach tissue, wherein the controller is configured to display said image representing at least a portion of the edge perimeter of the stomach tissue over at least a portion of said tissue image on said display ; and wherein said controller is further configured to generate said firing path based on the determined at least a portion of the perimeter of the stomach. said handle comprises a display , and the surgical stapler further comprises a vision system configured to capture a tissue image of the stomach tissue and a controller comprising an edge detection algorithm configured to determine at least a portion of the perimeter of the stomach tissue, wherein the controller is configured to generate an image representing at least a portion of the perimeter of the stomach tissue, wherein the controller is configured to display said image representing at least a portion of the edge perimeter of the stomach tissue over at least a portion of said tissue image on said display ; and wherein said controller is further configured to generate said firing path based on the determined at least a portion of the perimeter of the stomach.
Method for operating an electrosurgical generator configured to supply power to an electrosurgical instrument , the electrosurgical generator being identifiable by a serial number and comprising at least two modules , wherein the modules are embodied as hardware modules and/or as software modules, wherein each of the modules has a functionality according to an operation mode which is at least partially specified by a license key, wherein in an initializing process of the electrosurgical generator , identification information being indicative of a serial number is available or is made available at at least one of the modules and license information being indicative of a license key is available or is made available at at least one of the modules , each of the modules provides any of the identification information and the license information being available or being made available to it to at least one other of the modules , at least one of the modules generates a link of the identification information and the license information and provides the generated link to each of the other modules , and each of the modules stores the generated link.
A method for programmable logic controller (PLC) program randomization in a redundant PLC architecture system, the method comprising: a) receiving, by an engineering system computer, source code corresponding to a PLC program; b) compiling, by the engineering system computer , the source code into a plurality of functionally equivalent intermediate representations of the PLC program, wherein the program structure of the PLC program is randomized during compilation utilizing code and memory path randomization such that each intermediate representation is unique among the plurality of intermediate representations; and c) transmitting, by the engineering system computer, the plurality of intermediate representations to one or more PLCs ; and d1) receiving, by the PLC, a first intermediate representation of the PLC program; d2) compiling, by the PLC, the first intermediate representation into a PLC assembly code, wherein the program structure of the first intermediate representation is randomized during compilation; and d3) executing, by the PLC, the PLC assembly code; and e1) following failover of the PLC, re-compiling the first intermediate representation into a new PLC assembly code, wherein the program structure of the first intermediate representation is randomized during re-compilation; and e2) executing, by the PLC, the new PLC assembly code; wherein f) randomization occurs in two stages: at the high-level compile time where the PLC source code is transformed into the PLC intermediate representation; and at runtime where the PLC intermediate representation is transformed into assembly instructions for execution in the PLC processor. a) receiving, by an engineering system computer, source code corresponding to a PLC program; b) compiling, by the engineering system computer , the source code into a plurality of functionally equivalent intermediate representations of the PLC program, wherein the program structure of the PLC program is randomized during compilation utilizing code and memory path randomization such that each intermediate representation is unique among the plurality of intermediate representations; and c) transmitting, by the engineering system computer, the plurality of intermediate representations to one or more PLCs ; and d1) receiving, by the PLC, a first intermediate representation of the PLC program; d2) compiling, by the PLC, the first intermediate representation into a PLC assembly code, wherein the program structure of the first intermediate representation is randomized during compilation; and d3) executing, by the PLC, the PLC assembly code; and e1) following failover of the PLC, re-compiling the first intermediate representation into a new PLC assembly code, wherein the program structure of the first intermediate representation is randomized during re-compilation; and e2) executing, by the PLC, the new PLC assembly code; wherein f) randomization occurs in two stages: at the high-level compile time where the PLC source code is transformed into the PLC intermediate representation; and at runtime where the PLC intermediate representation is transformed into assembly instructions for execution in the PLC processor.
A primary drug container comprising: a housing containing a drug to be dispensed, the housing having a first end defining a first opening; a plunger , positioned within the housing , in contact with the drug ; and a first sealing element providing a first closure seal across the first opening of the housing; characterised in that the plunger does not form a closure seal with the housing and includes a hollow portion such that, in use, the drug is in contact with and presses against an interior wall of the hollow portion, so that a component of the fluid pressure exerted by the drug on the plunger when the plunger is moved to dispense the drug is directed towards a sealing interface between the plunger and the housing and thereby augments the seal between the plunger and the housing. a housing containing a drug to be dispensed, the housing having a first end defining a first opening; a plunger , positioned within the housing , in contact with the drug ; and a first sealing element providing a first closure seal across the first opening of the housing; characterised in that the plunger does not form a closure seal with the housing and includes a hollow portion such that, in use, the drug is in contact with and presses against an interior wall of the hollow portion, so that a component of the fluid pressure exerted by the drug on the plunger when the plunger is moved to dispense the drug is directed towards a sealing interface between the plunger and the housing and thereby augments the seal between the plunger and the housing.
An electrolyte comprising a lithium salt, a non-aqueous organic solvent, and an additive, and the additive comprising a compound represented by Formula I or Formula II: wherein, in Formula I, R 1 -R 6 are each independently selected from hydrogen atom, halogen atom, trialkylsilyl, an unsubstituted C1-C12 alkylene group, an unsubstituted C2 -C12 alkenylene group, and an unsubstituted C6-C26 arylene group; in Formula II, R 9 and R 12 are each independently selected from hydrogen atom, halogen atom, trialkylsilyl, an unsubstituted C1-C12 alkylene group, an unsubstituted C2 -C12 alkenylene group, and an unsubstituted C6-C26 arylene group, R 7 -R 8 and R 10 -R 11 are each independently selected from trialkylsilyl, an unsubstituted C1-C12 alkylene group, an unsubstituted C2-C12 alkenylene group, and an unsubstituted C6-C26 arylene group. wherein, in Formula I, R 1 -R 6 are each independently selected from hydrogen atom, halogen atom, trialkylsilyl, an unsubstituted C1-C12 alkylene group, an unsubstituted C2 -C12 alkenylene group, and an unsubstituted C6-C26 arylene group; in Formula II, R 9 and R 12 are each independently selected from hydrogen atom, halogen atom, trialkylsilyl, an unsubstituted C1-C12 alkylene group, an unsubstituted C2 -C12 alkenylene group, and an unsubstituted C6-C26 arylene group, R 7 -R 8 and R 10 -R 11 are each independently selected from trialkylsilyl, an unsubstituted C1-C12 alkylene group, an unsubstituted C2-C12 alkenylene group, and an unsubstituted C6-C26 arylene group.
A base station, BS, for handling a plurality of common search spaces, CSS, the BS comprising: at least one storage device ; and at least one processing circuit , coupled to the at least one storage device , wherein the at least one storage device stores, and the at least one processing circuit is configured to execute, instructions of: transmitting a first signaling for configuring a first group CSS on a first control resource set, CORESET, for a first communication device, to the first communication device; transmitting a second signaling for configuring a second group CSS on a second CORESET for a second communication device, to the second communication device; transmitting a third signaling for configuring the first group CSS on the first CORESET for the second communication device, to the second communication device; transmitting a first downlink, DL, control information, DCI, via the first group CSS to the first communication device and the second communication device; and transmitting a second DCI to the second communication device via the second group CSS. at least one storage device ; and at least one processing circuit , coupled to the at least one storage device , wherein the at least one storage device stores, and the at least one processing circuit is configured to execute, instructions of: transmitting a first signaling for configuring a first group CSS on a first control resource set, CORESET, for a first communication device, to the first communication device; transmitting a second signaling for configuring a second group CSS on a second CORESET for a second communication device, to the second communication device; transmitting a third signaling for configuring the first group CSS on the first CORESET for the second communication device, to the second communication device; transmitting a first downlink, DL, control information, DCI, via the first group CSS to the first communication device and the second communication device; and transmitting a second DCI to the second communication device via the second group CSS. transmitting a first signaling for configuring a first group CSS on a first control resource set, CORESET, for a first communication device, to the first communication device; transmitting a second signaling for configuring a second group CSS on a second CORESET for a second communication device, to the second communication device; transmitting a third signaling for configuring the first group CSS on the first CORESET for the second communication device, to the second communication device; transmitting a first downlink, DL, control information, DCI, via the first group CSS to the first communication device and the second communication device; and transmitting a second DCI to the second communication device via the second group CSS.
A method for isolating a bispecific antibody, the method comprising isolating the bispecific antibody using a Protein A affinity support and employing a pH gradient in the presence of an ionic modifier at a concentration of 0.15M - 1.0M; wherein the ionic modifier is a chloride salt of an alkali metal or an alkaline earth metal; wherein the bispecific antibody comprises two heavy chains that recognize two different epitopes or two different antigens and two light chains that have identical variable and constant domains; wherein the CH3 domain of one of the heavy chains is selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 3, and SEQ ID NO: 5 and the CH3 domain of the second heavy chain is selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, and SEQ ID NO: 6.
An antibacterial and antifungal preparation containing, beside the biologically active ingredient, auxiliary ingredients such as fillers, characterized in that it contains a biologically active ingredient being an acid with a formula 1 shown in the drawing, where R 1 and R 2 signify carboxyl groups (-COOH), R 3 , R 4 , R 5 , R 6 , R 7 signify hydrogen (H), X signifies nitrogen (N) and Y signifies carbon (C) in the amount of 60 to 85% by weight, and the remaining amount is a composition of inorganic and organic fillers.
A method comprising: receiving (302; 402), at an electronic device, a message; determining (304; 404) that the message includes a predetermined phrase; in response to determining that the message includes the predetermined phrase, audibly presenting (310; 410), at the electronic device, an alert that requests that a user speak a challenge phrase; in response to the alert, receiving (312; 412) an audio input at the electronic device; determining that the audio input includes the challenge phrase and an instruction including a command instructing the electronic device to perform an operation; and in response to determining that the audio input includes the challenge phrase and the instruction, processing the command. receiving (302; 402), at an electronic device, a message; determining (304; 404) that the message includes a predetermined phrase; in response to determining that the message includes the predetermined phrase, audibly presenting (310; 410), at the electronic device, an alert that requests that a user speak a challenge phrase; in response to the alert, receiving (312; 412) an audio input at the electronic device; determining that the audio input includes the challenge phrase and an instruction including a command instructing the electronic device to perform an operation; and in response to determining that the audio input includes the challenge phrase and the instruction, processing the command.